High prevalence of arrhythmia will drive the overall implantable cardioverter-defibrillators
market
The rising old age population and high occurrence of coronary artery diseases are some of the major
factors which will propel growth of the implantable cardioverter-defibrillators market. Sedentary
lifestyles, unhealthy dietary habits, and lack of proper exercise have resulted into the increased
incidences of heart related diseases, especially arrhythmia. The demand for ICDs is rising
significantly as healthcare professionals and the governing bodies such as American Heart
Association have widely accepted this form of treatment due to its safety, and efficacy. However,
the AHA recommends that the arrhythmia in question ought to be life threatening for the patient to
be eligible for a cardioverter defibrillator.
North America held the maximum market share in implantable cardioverter defibrillator market
globally. Favorable and constructive policies and regulations as well as availability of sophisticated
healthcare facilities along with rising approvals about the usage of implantable cardioverter-
defibrillators from the governing bodies are likely to fuel the growth of the implantable
cardioverter-defibrillators industry in this region.
For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/implantable-cardioverter-
defibrillators-market-223
Some of the key players operating in the global implantable cardioverter-defibrillators market are
Imricor Medical Systems, Boston Scientific Corporation, Inc., LivaNova PLC Company, MicroPort
Scientific Corporation, Mayo Clinic US, Medtronic plc, St. Jude Medical, Inc., and MRI
Interventions, Inc.
Implantable Cardioverter-defibrillators Market Taxonomy
On the basis of type of product, the global market is classified into:
•Biventricular Implantable Cardioverter Defibrillators
•Single Chambered
•Dual Chambered
On the basis of type of procedure, the global market is classified into:
•Subcutaneous Implantable Cardioverter Defibrillators
•Trans-Venous Implantable Cardioverter Defibrillators
On the basis of end user, the global market is classified into:
•Hospitals
•Specialty Clinics
•Ambulatory Surgical Centers
•Others
The subcutaneous ICD (S-ICD) is inserted without placing the leads into the heart. The device is
inserted below the left axilla, or armpit in line with the rib cage. The lead connected to the device is
laired under the skin more willingly than inside the heart. Some of the advantages of the S-ICD are
the lack of immediate or long-term complications caused by inserting a lead into the heart, such as
collapse of the lung and perforation of the heart. Subcutaneous implantable cardioverter